Our ETFs focus on precise investment opportunities in medicine. They are the CNCR Immunotherapy ETF and the CHNA BioPharma ETF. Both are proudly listed on Nasdaq.


Invest in the Future of Cancer Care with CNCR

The Cancer Immunotherapy ETF offers exposure to a basket of companies that develop therapies to treat cancer by harnessing the body's own immune system. Immunotherapy is a transformational field within the biotechnology space that may have a foundational impact on cancer care. CNCR seeks to support this important work and its positive impact on society.


Invest in China's BioPharma Industry with CHNA

The China BioPharma ETF offers exposure to a basket of companies powering China's biopharmaceutical industry. With a long-term goal of steering its economy towards innovation, China aims be a global leader in medicine. CHNA seeks to invest in this opportunity with the convenience of one security that trades in the United States.